ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
-0.08%
US Dollar vs AUD
1.53421
-0.14%
Bitcoin
96,528.82
-0.98%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pathfinder Cell Therapy Inc (CE) (PFND)

  7. Pathfinder Cell Therapy Inc (CE) (PFND) News

PFND

Pathfinder Cell Therapy (CE) (PFND)

Pathfinder Cell Therapy Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PFND
DateTimeSourceHeadlineSymbolCompany
05/04/201620:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
31/03/201607:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201608:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201606:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201604:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201604:37Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201604:37Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201604:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201604:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201621:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201621:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
17/03/201601:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
17/03/201601:56Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
05/12/201502:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
14/11/201503:23Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
05/11/201502:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
08/10/201500:19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
02/09/201504:12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
19/08/201502:20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
14/08/201502:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
21/07/201502:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
10/06/201505:24Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/05/201522:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
01/04/201503:19Edgar (US Regulatory)Annual Report (10-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
07/03/201506:55Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
04/02/201508:11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
01/01/201502:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/12/201400:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/11/201405:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/10/201402:33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
 Showing the most relevant articles for your search:USOTC:PFND

Your Recent History

TSXV
GCCC.H
GCC Global Capital
BIT
P73855
BNP Paribas
DGFX
MBPUSDT
MobiPad
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36